Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

GM CEO Says This Year Will Be The Year GM Pulls Away From Traditional Automakers

– Wolfe Conf.
byHappy Mohamed
February 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

– Wolfe Conf.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Datopotamab Deruxtecan Showed Encouraging and Durable Efficacy in Patients With Heavily Pretreated HR-positive, HER2-Low or Negative Metastatic Breast Cancer

By Charles Gross
Today, 6:10 AM
First results for AstraZeneca and Daiichi Sankyo's TROP2-directed ADC in this setting reported from TROPION-PanTumor01 Phase I trial. Pivotal TROPION-Breast01 Phase III trial is ongoing, evaluating datopotamab deruxtecan in these patients in earlier lines of treatment.

AZN